Torii Pharmaceutical Co., Ltd.
TRXPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $6,725,000 | $4,119,000 | $5,722,000 | $4,767,000 |
| Dep. & Amort. | $408,000 | $459,000 | $454,000 | $413,000 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$1,861,000 | -$6,826,000 | -$1,157,000 | -$5,649,000 |
| Other Non-Cash | -$1,633,000 | -$875,000 | -$2,599,000 | $313,000 |
| Operating Cash Flow | $3,639,000 | -$3,123,000 | $2,420,000 | -$156,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$152,000 | -$216,000 | -$281,000 | -$374,000 |
| Net Acquisitions | $0 | $0 | $0 | -$224,000 |
| Inv. Purchases | -$31,072,000 | -$26,589,000 | -$31,445,000 | -$24,476,000 |
| Inv. Sales/Matur. | $29,500,000 | $23,027,000 | $17,664,000 | $23,780,000 |
| Other Inv. Act. | -$1,847,000 | -$1,000 | $386,000 | -$204,000 |
| Investing Cash Flow | -$3,571,000 | -$3,779,000 | -$13,676,000 | -$1,498,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$348,000 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$2,000 | $0 | $0 | $0 |
| Dividends Paid | -$3,654,000 | -$3,540,000 | -$1,348,000 | -$1,348,000 |
| Other Fin. Act. | -$288,000 | -$295,000 | -$2,000 | -$198,000 |
| Financing Cash Flow | -$3,944,000 | -$3,835,000 | -$1,698,000 | -$1,546,000 |
| Forex Effect | $0 | $0 | $0 | -$2,000 |
| Net Chg. in Cash | -$3,876,000 | -$10,739,000 | -$12,954,000 | -$3,202,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $34,681,000 | $45,420,000 | $58,374,000 | $61,576,000 |
| End Cash | $30,805,000 | $34,681,000 | $45,420,000 | $58,374,000 |
| Free Cash Flow | $3,459,000 | -$3,339,000 | $2,139,000 | -$530,000 |